MSH|^~\&|LAB|RCH|||201911081433||ORU^R01|4103185|D|2.3|||AL|NE
PID|1||RC00006013|RC6013|FHWHITTALL^PLIS^||19680422|F||||||||||RC000015/17|9698717071
OBR|1|35046^LAB|00026909^0811:HC00010R^LAB^081119:HC10^35046|220.8900^INR^INR^^^6301-6||201911081432|201911081432|||||||201911081432||||||||||LAB|F||||
OBX|1|ST|220.9000^INR R^INR^^6301-6^6301-6|1|1.0^^Y||0.8-1.2|N||A^S|F|||201911081433
NTE|1||INR Therapeutic Ranges:
NTE|2||    Mechanical Heart Valves 2.5 - 3.5
NTE|3||    Other indications       2.0 - 3.0
OBR|2|35046^LAB|00026909^0811:HC00010R^LAB^081119:HC10^35046|220.9600^PTT^Partial Thromboplastin Time^^14979-9^14979-9||201911081432|201911081432|||||||201911081432||||||||||LAB|F||||
OBX|1|ST|220.9600^PTT^Partial Thromboplastin Time^^14979-9^14979-9|1|31^^Y|s|23-32|N||A^S|F|||201911081433
NTE|1||Note: New reference range as of Sept 18, 2019
NTE|2||
NTE|3||New Therapeutic Range for FULL DOSE Unfractionated Heparin:
NTE|4||60 - 90 secs
NTE|5||For low dose and other indications, refer to appropriate
NTE|6||nomograms.
NTE|7||
NTE|8||Note: The previous full dose unfractionated heparin
NTE|9||therapeutic range was 75-99 secs
OBR|3|35046^LAB|00026909^0811:HC00010R^LAB^081119:HC10^35046|231.2500^PF4^Anti-Platelet Factor 4 Group^^^34701-3||201911081432|201911081432|||||||201911081432||||||||||LAB|F||||
OBX|1|ST|231.2485^HIT R^Platelet PF4 Antibodies^^45155-9^|1|<1.0^^Y|U/mL|<1.0|N||A^S|F|||201911081433
NTE|1||HIT Screen Negative.
OBX|2|ST|231.2560^PF4PC^PF4 Comment^PF4^X10011^XXX-0039|1|^^N|||N||A^S|F|||201911081433
NTE|1||PATH COMMENT ADDED